Revised forecast
Fiscal year ending December 2026 · Full yearPrevious forecast published As of 7 AugustThe bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
The forecast for Advanced Materials and Semiconductors was revised upward based on performance trends through the third quarter and recent order trends. The operating profit forecast for Energy and Environment was revised downward due to lower profitability resulting from decreased sales caused by stagnation in the European hydrogen-related market, among other factors. The operating profit forecast for Bio and Healthcare was revised downward after taking into account the increased cost burden from higher investment in the life sciences field, among other factors.
Total extraordinary losses: ¥651 million (loss on sale of property, plant and equipment: ¥0 million; loss on disposal of property, plant and equipment: ¥63 million; business structure improvement costs: ¥469 million; retirement benefit expenses: ¥94 million; loss on sale of shares in subsidiaries: ¥23 million)
| Item | Details |
|---|---|
| Net Sales | 382,000 Millions of yen → 392,500 Millions of yen |
| Operating profit | 70,000 Millions of yen → 73,000 Millions of yen |
| Ordinary income | 71,000 Millions of yen → 74,000 Millions of yen |
| Profit attributable to owners of the parent | 50,000 Millions of yen → 51,500 Millions of yen |
| Net income per share | Not disclosed → ¥1,225.56 / sen |
| Fiscal Period Covered | Fiscal year ending December 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | As of 7 August |
| Previous-period results | Net sales ¥333,081 million, operating income ¥53,040 million, ordinary income ¥54,226 million, and net income attributable to owners of the parent ¥37,090 million |
| Reason for the revision | The forecast for Advanced Materials and Semiconductors was revised upward based on performance trends through the third quarter and recent order trends. The operating profit forecast for Energy and Environment was revised downward due to lower profitability resulting from decreased sales caused by stagnation in the European hydrogen-related market, among other factors. The operating profit forecast for Bio and Healthcare was revised downward after taking into account the increased cost burden from higher investment in the life sciences field, among other factors. |
| Details and amount of extraordinary loss | Total extraordinary losses: ¥651 million (loss on sale of property, plant and equipment: ¥0 million; loss on disposal of property, plant and equipment: ¥63 million; business structure improvement costs: ¥469 million; retirement benefit expenses: ¥94 million; loss on sale of shares in subsidiaries: ¥23 million) |
| Dividend forecast revision | No revision. The year-end dividend is forecast at ¥640 per share, and the annual dividend at ¥790. |
| Consolidated / non-consolidated | Consolidated |
The reasons the company gives
The company's own explanation, not something inferred from the numbers.For Advanced Materials and Semiconductors, sales and profit forecasts were revised upward based on results through the third quarter and recent order trends. For Energy and Environment, operating profit was revised downward due to lower sales and reduced profitability resulting from stagnation in the European hydrogen-related market. For Bio and Healthcare, operating profit was revised downward due to the increased cost burden from higher investment in the life sciences field.